Important Information

and 20th Anniversary Celebration
November 12-15, 2014
Realizing the Dream of Precision Medicine
With special address by Dr. Francis Collins

Corporate Workshop Day
November 12, 2014

Special Address by Dr. Francis Collins
November 12, 2014

Molecular Pathology Outreach Course
November 12, 2014

Exhibit Dates
November 13-15, 2014

Gaylord National Resort & Convention Center
National Harbor, MD
(Just outside Washington, DC)

Early (Reduced) Registration
September 10, 2014
Advance Registration
October 20, 2014
Hotel Reservations
October 20, 2014

How to Help

Corporate Support Opportunities
Donate to AMP


Linked In FaceBook Twitter
Project management using Podio


More Information

Economic Affairs Committee

Jan Nowak, MD, PhD


Aaron Bossler, MD, PhD (Co-Chair)

Committee Members

Annual Committee Report

Committee/Subdivision Purpose and Responsibilities

AMP Position Statements and Letters


economic affairs committee

Economic Affairs Committee

Economic Affairs Committee

The purpose of the Economic Affairs Committee (EAC) is to address, advise, and educate the AMP Council, membership, payers, legislators, and the public on economic issues of importance to the field of molecular pathology, to prepare documents of importance to the Centers for Medicare & Medicaid Services (CMS), and to develop and advocate for sound economic polices that promote the provision of high quality molecular pathology services.  The Committee's scope encompasses short and long-term issues associated with utilization of and coverage for billing codes used in molecular pathology, to the potential economic impact of public policy decisions on molecular pathology practice.  The Committee will interact with the American Medical Association and other interested organizations in order to achieve our common goals.

EAC Updates

AMP Releases Proposal Addressing CPT Coding for GSAs - Your Input is Requested!

March 2013: The AMP Economic Affairs Committee report to AMA documents the challenges, related technology, and proposed coding scheme for GSAs. Input from AMP members is requested no later than April 15, 1013. More Information...

View the Proposal

View the full Press Release

2013 Molecular Pathology CPT Code Gapfill Process Notice: Several regional Medicare Adminstrative Contractors (MACs) Several MACs have released their preliminary fee schedules for molecular tests. These fee schedules are still subject to modification, but it is important that every molecular pathology laboratory provide its regional MAC with data that can be used to set appropriate reimbursement values. AMP members should endeavor to bring this important issue to the attention of their department chairs and the billing officers of their institutions. Some Medicare contractors have set response deadline as early as March 31, so there is no time to delay.

More information (PDF). Direct Costs - technical inputs (XLSX). AMA RUC-Recommended Physician Resources (Federal Register, begnning p. 69000) (PDF)


December 28, 2012: AMP comments to CMS regarding the 2013 PFS Final Rule.
Read the letter

July 23, 2012: AMP Provides Comments to CMS Clinical Lab Fee Schedule.

View the presentation to CMS and additional written comments

March 10, 2011: AMA CPT Panel released the outline of a new coding system for molecular pathology assays in genetics, oncology and histocompatibility.  The system is based on the EAC White Paper: Proposal for CPT Coding Reform for Molecular Diagnostics.